CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
0.867
-0.004 (-0.41%)
At close: Nov 21, 2024, 4:00 PM
0.885
+0.018 (2.14%)
After-hours: Nov 21, 2024, 7:12 PM EST

CytomX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
68104106283303378
Upgrade
Market Cap Growth
7.02%-1.80%-62.58%-6.69%-19.81%-44.44%
Upgrade
Enterprise Value
-39-75-7069780
Upgrade
Last Close Price
0.871.551.604.336.558.31
Upgrade
Forward PE
-16.30----
Upgrade
PS Ratio
0.571.031.997.574.4214.03
Upgrade
PB Ratio
-3.93-2.19-1.23-615.53-38.957.39
Upgrade
P/TBV Ratio
-----7.73
Upgrade
P/FCF Ratio
----102.63-
Upgrade
P/OCF Ratio
----57.57-
Upgrade
EV/Sales Ratio
---1.840.112.98
Upgrade
EV/FCF Ratio
----2.48-
Upgrade
Debt / Equity Ratio
-0.45-0.29-0.21-47.22-3.200.54
Upgrade
Debt / FCF Ratio
----8.43-
Upgrade
Asset Turnover
0.700.440.180.110.200.07
Upgrade
Quick Ratio
1.011.141.503.934.653.46
Upgrade
Current Ratio
1.041.171.553.984.763.54
Upgrade
Return on Equity (ROE)
-----299.13%-145.96%
Upgrade
Return on Assets (ROA)
2.33%-1.75%-19.54%-20.78%-14.38%-22.15%
Upgrade
Return on Capital (ROIC)
----378.62%-104.99%-84.35%
Upgrade
Earnings Yield
20.14%-0.55%-93.93%-41.01%-21.41%-35.18%
Upgrade
FCF Yield
-129.30%-54.78%-106.42%-42.70%0.97%-38.13%
Upgrade
Buyback Yield / Dilution
-19.68%-12.27%-2.48%-39.01%-1.79%-8.81%
Upgrade
Total Shareholder Return
-19.68%-12.27%-2.48%-39.01%-1.79%-8.81%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.